THE PREVALENCE OF EFFECTIVENESS  OF BOLUS DOSE OF I/V HYDRALAZINE VERSUS I/V LABETALOL FOR THE EARLIER CONTROL OF BLOOD PRESSURE IN SEVERE PREECLAMPTIC PATIENT: A COMPARATIVE STUDY

S KUMARI; S DARS; SS ZAHRA; N PAWAN; R AHMED

doi:10.54112/bcsrj.v2022i1.147

Authors

S KUMARI Department of Obstetrics and Gynecology, Foundation Medical Complex Hyderabad-Pakistan
S DARS Department of Obstetrics and Gynecology, Liaquat University of Medical & Health Sciences(LUMHS) Jamshoro-Pakistan
SS ZAHRA Department of Obstetrics and Gynecology, Razia Iqbal Medical Center Multan-Pakistan
N PAWAN Department of Obstetrics and Gynecology, Sobhraj Maternity Hospital, Karachi-Pakistan
R AHMED Department of Biochemistry, Independent Medical College Faisalabad-Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2022i1.147

Keywords:

Preeclampsia, Hydralazine, Labetalol, Blood pressure

Abstract

To compare the efficacy of hydralazine and labetalol for the management of blood pressure in patients with severe preeclampsia to improve maternal and fetal outcomes. 6 months from March 2022 to September 2022 in the Department of obstetrics and gynecology, Liaquat University Hospital, Hyderabad and Razia Iqbal Hospital Multan, a Cross-sectional study was carried out. The study was conducted on 57 women diagnosed with severe preeclampsia. The subjects were divided into two groups. Group A was administrated I/V hydralazine bolus doses of 5 mg over 2 minutes with an interval of 20 minutes. Group B was administered I/V labetalol bolus doses of 20mg over 2 minutes at an interval of 10 minutes. The average age of the patients was 25.58±3.89 years. The efficacy of bolus dose of hydralazine (82.1%) and labetalol (75.9%) was statistically insignificant (p=0.56). The average time was 52 minutes the total hydralazine was 12.25 mg, in the case of the labetalol group the average time was 18.62 minutes, and the total dose was 68.28 mg. Both hydralazine and labetalol have similar efficacy as antihypertensive medications and can be used to treat hypertensive disorders in pregnant women.

Downloads

Download data is not yet available.

References

Cox, A. G., Marshall, S. A., Palmer, K. R., and Wallace, E. M. (2019). Current and emerging pharmacotherapy for emergency management of preeclampsia. Expert Opinion on Pharmacotherapy20, 701-712.

Filipek, A., and Jurewicz, E. (2018). Preeclampsia-a disease of pregnant women. Postepy biochemii64, 232-229.

Fox, R., Kitt, J., Leeson, P., Aye, C. Y., and Lewandowski, A. J. (2019). Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. Journal of clinical medicine8, 1625.

GUL, S., NAZ, A., NISAR, M., AKHTAR, R., YASMEEN, S., and SHAMS, G. (2019). COMPARISON OF EFFICACY OF ORAL NEFIDIPINE VS. INTRAVENOUS HYDRALAZINE IN SEVERE PREECLAMPTIC PATIENTS. KJMS12, 482.

Kumari, A., Rohatgi, R., Singh, A., and Kumar, R. (2020). Comparative study of intravenous hydralazine and labetalol in severe hypertensive disorders of pregnancy. International Journal of Reproduction, Contraception, Obstetrics and Gynecology9, 675-682.

Macedo, T. C., Montagna, E., Trevisan, C. M., Zaia, V., de Oliveira, R., Barbosa, C. P., Laganà, A. S., and Bianco, B. (2020). Prevalence of preeclampsia and eclampsia in adolescent pregnancy: A systematic review and meta-analysis of 291,247 adolescents worldwide since 1969. European Journal of Obstetrics & Gynecology and Reproductive Biology248, 177-186.

Magee, L. A., Abalos, E., von Dadelszen, P., Sibai, B., Easterling, T., Walkinshaw, S., and Group, C. S. (2011). How to manage hypertension in pregnancy effectively. British journal of clinical pharmacology72, 394-401.

NAZ, A., and JAWAD, Z. Comparison of Role of Hydralazine Vs Labetalol in Mean Reduction of Mean Arterial Pressure in patients with Severe Preeclampsia.

Pandey, U. (2018). EFFICACY OF LABETALOL IN PREECLAMPSIA. Indian Obstetrics and Gynaecology8.

Patel, P., Koli, D., Maitra, N., Sheth, T., and Vaishnav, P. (2018). Comparison of efficacy and safety of intravenous labetalol versus hydralazine for management of severe hypertension in pregnancy. The Journal of Obstetrics and Gynecology of India68, 376-381.

Program, N. H. B. P. E. (2000). Report of the national high blood pressure education program working group on high blood pressure in pregnancy. American journal of obstetrics and gynecology183, s1-s22.

Rana, S., Lemoine, E., Granger, J. P., and Karumanchi, S. A. (2019). Preeclampsia: pathophysiology, challenges, and perspectives. Circulation research124, 1094-1112.

Rose, D. T., and Jeyarani, P. (2019). Comparative study of labetalol and nifedipine in management of nonsevere preeclampsia and its fetomaternal outcome. International Journal of Reproduction, Contraception, Obstetrics and Gynecology8, 2034-2039.

Snydal, S. (2014). Major changes in diagnosis and management of preeclampsia. Journal of midwifery & women's health59, 596-605.

Syed, M., Faisal, R., Shinwari, L., Aman, A., and Nawaz, R. (2020). EFFICACY OF HYDRALAZINE IN COMPARISON WITH LABETALOL FOR CONTROL OF SEVERE HYPERTENSION IN PATIENTS WITH ECLAMPSIA. Pakistan Armed Forces Medical Journal70.

Verma, M., Gupta, S., Bhagat, B., Mahajan, A., and Kaur, B. (2018). Comparison of intravenous hydralazine and intravenous labetalol in the management of severe hypertensive disorders of pregnancy: a tertiary care centre study. Int J Reprod Contracept Obstet Gynecol7, 2251-56.

Vigil-De Gracia, P., Lasso, M., Ruiz, E., Vega-Malek, J. C., de Mena, F. T., and López, J. C. (2006). Severe hypertension in pregnancy: hydralazine or labetalol: a randomized clinical trial. European Journal of Obstetrics & Gynecology and Reproductive Biology128, 157-162.

Vigil-De Gracia, P., Ruiz, E., López, J. C., Alveo de Jaramillo, I., Vega-Maleck, J. C., and Pinzón, J. (2007). Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial. Hypertension in Pregnancy26, 163-171.

Wu, H.-Z., Cheng, Y., Yu, D., Li, J.-B., Jiang, Y.-F., and Zhu, Z.-N. (2022). Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials. Hypertension in Pregnancy41, 126-138.